BrainSight AI has secured a $5 million Pre-series A investment led by IAN Alpha Fund to enhance its innovative neuroinformatics platform and expand its market presence in India and beyond.
Target Information
BrainSight AI, a deep-tech startup based in Bengaluru, specializes in neuroscience with a focus on developing innovative solutions for the diagnosis and treatment of complex brain disorders. Founded in 2019 by Laina Emmanuel and Dr. Rimjhim Agrawal, the company has established a notable presence in the healthcare sector. With its cutting-edge neuroinformatics platform, VoxelBox, BrainSight AI seeks to revolutionize patient care through precise and personalized treatment options for brain-related conditions.
The company currently collaborates with over 40 leading hospitals across India, emphasizing neurosurgery and radiology, particularly in brain tumor cases. As it aims to extend its offerings to include neurological and psychiatric disorders, BrainSight AI demonstrates a commitment to a more comprehensive approach to brain health that encompasses a broad spectrum of patient needs.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in India
India's healthcare industry is experiencing rapid growth, fueled by increasing healthcare spending, technology adoption, and a rising demand for quality medical services. The nation’s healthcare market is projected
Similar Deals
Rajesh Ranavat, Abhishek Shah, Kabir Kochhar, Mohit Satyanand → Bold Care
2023
IAN Alpha Fund
invested in
BrainSight AI
in 2023
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $5M